These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32524557)

  • 1. Generation of Cerebral Cavernous Malformation in Neonatal Mouse Models Using Inducible Cre-LoxP Strategy.
    Choi JP; Zheng X
    Methods Mol Biol; 2020; 2152():253-258. PubMed ID: 32524557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease.
    Goitre L; Fornelli C; Zotta A; Perrelli A; Retta SF
    Methods Mol Biol; 2020; 2152():151-167. PubMed ID: 32524551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
    Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
    Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
    Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
    J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model.
    Zhou HJ; Qin L; Jiang Q; Murray KN; Zhang H; Li B; Lin Q; Graham M; Liu X; Grutzendler J; Min W
    Nat Commun; 2021 Jan; 12(1):504. PubMed ID: 33495460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
    Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and Purification of Mouse Brain Endothelial Cells to Study Cerebral Cavernous Malformation Disease.
    Hale P; Soliman SI; Sun H; Lopez-Ramirez MA
    Methods Mol Biol; 2020; 2152():139-150. PubMed ID: 32524550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
    McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
    Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Report of Concomitant Pathogenic Mutations Within MGC4607/CCM2 and KRIT1/CCM1 in a Familial Cerebral Cavernous Malformation Patient.
    da Fontoura Galvão G; Veloso da Silva E; Fontes-Dantas FL; Filho RC; Alves-Leon S; Marcondes de Souza J
    World Neurosurg; 2020 Oct; 142():481-486.e1. PubMed ID: 32615293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
    Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
    Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.
    Retta SF; Perrelli A; Trabalzini L; Finetti F
    Methods Mol Biol; 2020; 2152():3-25. PubMed ID: 32524540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
    Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
    Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
    Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
    Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.
    Jenny Zhou H; Qin L; Zhang H; Tang W; Ji W; He Y; Liang X; Wang Z; Yuan Q; Vortmeyer A; Toomre D; Fuh G; Yan M; Kluger MS; Wu D; Min W
    Nat Med; 2016 Sep; 22(9):1033-1042. PubMed ID: 27548575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral cavernous malformations arise independent of the heart of glass receptor.
    Zheng X; Riant F; Bergametti F; Myers CD; Tang AT; Kleaveland B; Pan W; Yang J; Tournier-Lasserve E; Kahn ML
    Stroke; 2014 May; 45(5):1505-1509. PubMed ID: 24643410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
    Pagenstecher A; Stahl S; Sure U; Felbor U
    Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EndMT contributes to the onset and progression of cerebral cavernous malformations.
    Maddaluno L; Rudini N; Cuttano R; Bravi L; Giampietro C; Corada M; Ferrarini L; Orsenigo F; Papa E; Boulday G; Tournier-Lasserve E; Chapon F; Richichi C; Retta SF; Lampugnani MG; Dejana E
    Nature; 2013 Jun; 498(7455):492-6. PubMed ID: 23748444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model.
    Choi JP; Yang X; Foley M; Wang X; Zheng X
    J Vis Exp; 2017 Sep; (127):. PubMed ID: 28892037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
    Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
    Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.
    Choi JP; Foley M; Zhou Z; Wong WY; Gokoolparsadh N; Arthur JS; Li DY; Zheng X
    PLoS One; 2016; 11(8):e0160833. PubMed ID: 27513872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.